Dr. Boudewijn Van Lent Ph.D. Net Worth

Dr. Boudewijn Van Lent Ph.D. biography

Dr. Boudewijn Van Lent Ph.D. is the Exec. VP & Global Head of Specialty Construction Chemicals at GCP Applied Technologies Inc.

How old is Dr D?

Dr D is 57, he's been the Exec. VP & Global Head of Specialty Construction Chemicals of GCP Applied Technologies Inc since . There are 5 older and 6 younger executives at GCP Applied Technologies Inc. The oldest executive at GCP Applied Technologies Inc is Clay Kiefaber, 63, who is the Independent Director.

What's Dr D's mailing address?

Lent's mailing address filed with the SEC is C/O GCP APPLIED TECHNOLOGIES INC., 62 WHITTEMORE AVE, CAMBRIDGE, MA, 02140.

Insiders trading at GCP Applied Technologies Inc

Over the last 9 years, insiders at GCP Applied Technologies Inc have traded over $216,521 worth of GCP Applied Technologies Inc stock and bought 10,576,218 units worth $293,334,012 . The most active insiders traders include Peter A Feld, Investments Llc Standard In... oraz Gregory E Poling. On average, GCP Applied Technologies Inc executives and independent directors trade stock every 60 days with the average trade being worth of $12,151,924. The most recent stock trade was executed by Armand F Jr Lauzon on 17 November 2020, trading 16,000 units of GCP stock currently worth $389,760.

What does GCP Applied Technologies Inc do?

GCP is a leading global provider of construction products technologies that include additives for cement and concrete, the VERIFI® in-transit concrete management system, high-performance waterproofing products, and specialty systems. GCP products have been used to build some of the world's most renowned structures.

GCP Applied Technologies Inc executives and stock owners

GCP Applied Technologies Inc executives and other stock owners filed with the SEC include:

• Kevin Holland,
  Chief Human Resource Officer, Vice President
• Simon M. Bates,
  Pres, CEO & Director
• Craig A. Merrill,
  VP & CFO
• Simon Bates,
  President, Chief Executive Officer, Director
• Robert Yanker,
  Director
• Linda Welty,
  Director
• Andrew Ross,
  Director
• Janet Giesselman,
  Director
• Peter Feld,
  Independent Chairman of the Board
• Kevin Brown,
  Director
• Craig Merrill,
  Chief Financial Officer
• Marran Ogilvie,
  Independent Director
• Clay Kiefaber,
  Independent Director
• James Thompson,
  Vice President, General Counsel, Secretary
• David Campos,
  Pres of SCC Americas
• Sherry Mennenga,
  Chief HR Officer
• William I. Kent,
  VP of Investor Relations and Corp. Devel.
• Dr. Boudewijn Van Lent Ph.D.,
  Exec. VP & Global Head of Specialty Construction Chemicals
• Carolyn James,
  Interim Chief HR Officer
• Michael W. Valente,
  VP, Gen. Counsel & Sec.
• Betsy Cowell,
  VP of Fin. & Investor Relations
• Robyn Hooker-McCall,
  Chief Information Officer
• James Waddell,
  Chief Accounting Officer
• Randall S. Dearth,
  President and CEO
• James Waddell,
  Chief Accounting Officer
• Gerard G Colella,
  Director
• Danny R Shepherd,
  Director
• Phillip J Mason,
  Director
• John W. Kapples,
  VP and GC
• Saber Zain Mahmood,
  President, SBM and Global Ops
• Janice K Henry,
  Director
• Marcia J Avedon,
  Director
• Dean P Freeman,
  VP and CFO
• Gregory E Poling,
  President and CEO
• Ronald C Cambre,
  Director
• Elizabeth Mora,
  Director
• William J. Mc Call,
  Vice President and CHRO
• Marye Anne Fox,
  Director
• Naren B Srinivasan,
  EVP, SBM
• Kenneth S Korotkin,
  VP and Controller
• Investments Llc Standard In...,
  
• James F Kirsch,
  Director
• Lent Boudewijn Van,
  EVP, SCC
• R Grace & Co W,
  10% owner
• David Campos,
  President, SCC Americas
• Michael W Valente,
  See Remarks
• Sherry Mennenga,
  Chief Human Resources Officer
• Armand F Jr Lauzon,
  Director
• Latitude Fund Lp Standard L...,